A fungicide for preventing and controlling kiwifruit canker and citrus canker and its application

By using microcapsule suspension agent prepared by oregano oil and carvacrol, the problem of poor effectiveness in preventing and treating kiwi fruit ulcers and citrus ulcers in the prior art was solved, efficient and residual disease control was achieved, and crop quality was significantly improved .

CN117581868BActive Publication Date: 2024-11-12GUO WUYANG (HUNAN) BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311582049.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-11-24
Publication Date
2024-11-12
Estimated Expiration
2043-11-24

AI Technical Summary

Technical Problem

The prior art is not effective in preventing and treating kiwi fruit ulcers and citrus ulcers, and common fungicides have drug resistance, residues and environmental pollution problems, making it difficult to effectively inhibit bacterial diseases.

Method used

Organo oil and carvacrol are used as active ingredients, and the microcapsule suspension is wrapped by preparing microcapsule suspension agent, combining polyhydroxybutyrate and polybutylene succinate as wall materials to form a stable microcapsule structure and improve bioavailability. Rate and field prevention efficiency.

Benefits of technology

It significantly improves the prevention and treatment effect of kiwi fruit ulcer disease and citrus ulcer disease, takes effect quickly and has no residues, improves crop quality, and has a better inhibitory effect than traditional dosage forms.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117581868B_ABST
    Figure CN117581868B_ABST
Patent Text Reader

Abstract

The invention discloses a fungicide for preventing and treating kiwifruit canker and citrus canker and its application, wherein the fungicide comprises an active ingredient, wherein the active ingredient is one or more of oregano oil and carvacrol. The invention can effectively inhibit citrus canker pathogens from the source, has a fast onset of action, has no residue, improves the quality of citrus, and has a better effect than 77% basic copper sulfate water dispersible granules. The invention can effectively inhibit kiwifruit canker pathogens from the source, has a fast onset of action, has no residue, improves the quality of kiwifruit, and has a better effect than 5% kasugamycin aqueous solution.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of botanical fungicides, in particular to a fungicide for preventing and treating kiwifruit canker and citrus canker and its application. Background Art

[0002] The harm caused by plant pathogens seriously threatens the yield and quality of environmental crops. Among them, bacterial diseases such as kiwi canker, citrus canker, citrus Huanglongbing, tomato bacterial wilt, and rice white leaf blight have a particularly serious impact on the industry, not only leading to reduced production and loss of harvest, but also possibly destroying the orchard and causing no harvest. At present, the main methods for preventing and controlling bacterial diseases include inorganic copper, organic copper, antibiotics, and microbial pesticides. Copper preparations for bacterial diseases are widely used in production, including copper hydroxide, copper oxychloride, and basic copper sulfate. The active ingredients have a single target, and long-term use has caused bacteria to develop high drug resistance. In addition, the use of inorganic copper preparations at high temperatures is prone to produce pesticide damage and stimulate the occurrence of red spiders; bacterial diseases show cross-resistance to organic copper preparations such as quinoline copper and inorganic copper preparations, and the field control effect is not good; microbial pesticides such as Bacillus subtilis are extremely unstable and have poor rapidity; antibiotics such as tetramycin, kasugamycin, and zhongshengmycin have weak resistance to rain erosion and poor permeability, and are not effective in protecting crops in the continuous rainy conditions in the south, and cannot be mixed with alkaline pesticides. The existing product registration dosage forms are mainly wettable powders, emulsifiable concentrates, aqueous solutions, soluble liquids, water-dispersible granules, etc. This type of dosage form cannot transmit active ingredients to the phloem, and the permeability and resistance to rain erosion are not ideal, and the control effect on bacterial diseases is not good. Therefore, the development of fungicides with unique mechanisms of action and excellent biological activity has always been a research hotspot in the field of new pesticides, especially the exploration of plant-derived active ingredients with high antibacterial activity and the development of environmentally friendly agricultural fungicides are very promising.

[0003] Oregano oil is an active essential oil component extracted from oregano plant raw materials, which has multiple biological functions, including sterilization, insecticide, disinfection, anti-oxidation, and antiseptic. Oregano oil is a safe, efficient, green, and incompatible pure natural high-active ingredient Chinese medicine additive. It is one of the feed drug additives approved for use in my country, and its safety to animals and non-target organisms has been fully evaluated. Chinese invention patent application CN112219865A discloses that it has a strong inhibitory effect on corn leaf spot mildew, Rhizoctonia solani, rapeseed sclerotinia, tomato gray mold, wheat fusarium, watermelon vine blight, cotton wilt, rice blast, pepper phytophthora, apple anthracnose, sharp knife fusarium, avena fusarium, equisetum fusarium, sharp spore anthracnose, solanum rot fusarium, fine polar alternaria, citrus canker and potato black leg fungus, especially showing excellent inhibitory effect on Rhizoctonia solani. However, the results of the biological activity test of oregano oil dispersion system against bacterial diseases citrus canker and potato blackleg fungus showed that the inhibition rate reached 100% at a concentration of 250 μg / ml, and the inhibition rate was only 63.2% and 39.9% at a concentration of 125 μg / ml. However, there is no report on the use of oregano oil to prevent and treat kiwifruit canker.

[0004] Carvacrol is the main component of oregano oil. It can be separated and purified from oregano oil, or extracted from a variety of aromatic plant materials such as oregano, thyme and agave. Because it has no toxic side effects, no residue, and no pollution to the environment, it is often added to cosmetics as a fragrance. It is also used as an antibacterial agent and preservative for food preservation. Medical research has found that carvacrol also has biological activities such as tumor inhibition, anti-inflammatory, antioxidant, blood sugar regulation, and anti-parasitic. The China Pesticide Information Network announced that carvacrol (5% carvacrol aqueous solution, registration certificate number PD20171458) is registered for use in citrus psyllids, citrus red spiders, rice planthoppers, tobacco virus diseases, tobacco brown spot disease, tobacco powdery mildew, tomato gray mold, tea green leafhoppers, potato late blight, cucumber bacterial angular spot disease, etc. Chinese invention patent application CN109006855A discloses an insecticidal composition containing sulfoxaflor and carvacrol, wherein the active ingredients are composed of sulfoxaflor and carvacrol, wherein the weight ratio of sulfoxaflor and carvacrol is 1 to 40:1. It is suitable for the prevention and control of tea green leafhoppers, can delay the development of pest resistance, reduce the number of applications, improve the prevention and control effect, and is also conducive to reducing chemical pesticide residues. Chinese invention patent application CN108605939A discloses a fungicide composition containing carvacrol and ethimol, wherein the active ingredients are composed of carvacrol and ethimol, and the weight ratio is 1:10 to 30. The fungicide composition rationally mixed with carvacrol and ethimol is used to prevent and control powdery mildew of crops, has obvious synergistic effect, long lasting effect, and is conducive to prolonging the life cycle of ethimol. Chinese invention patent application CN 109090110A also discloses a fungicide composition containing carvacrol and fluopicolide as active ingredients, including common adjuvants, carvacrol and fluopicolide, and the mass ratio of carvacrol to fluopicolide is 3:1 to 1:5, preferably 1:1 to 1:3. Carvacrol and fluopicolide have a synergistic effect on pathogenic fungi such as tomato leaf mold after being compounded in a certain ratio, and are suitable for preventing and controlling crop diseases caused by pathogenic fungi such as tomato leaf mold. However, there has been no report on carvacrol for preventing and controlling citrus canker and kiwi canker diseases.

[0005] Chinese invention patent CN108835110B discloses a pesticide sustained-release microsphere and a preparation method thereof. The pesticide sustained-release microsphere of the invention is composed of a core material and a wall material in a mass ratio of 1: (1 to 6), wherein the core material is the pesticide original drug, and the wall material is composed of polylactic acid (PLA) and polybutylene succinate (PBS) (mass ratio is 1:1 to 9). Summary of the invention

[0006] The technical problem to be solved by the present invention is to provide an agricultural fungicide and its application, which can be used to prevent and control the harm of bacterial pathogens, especially a fungicide and its application for preventing and controlling kiwifruit canker and citrus canker, with fast onset of action, no residue, and improving the quality of kiwifruit and citrus.

[0007] In order to solve the above technical problems, the technical solution adopted by the present invention is: a fungicide for preventing and treating kiwifruit canker and citrus canker, the fungicide comprising active ingredients, and the active ingredients are one or more of oregano oil and carvacrol.

[0008] The invention provides one or more plant extracts of oregano oil and carvacrol capable of inhibiting pathogens of citrus canker and kiwifruit canker, and the occurrence of citrus canker and kiwifruit canker is controlled by inhibiting the growth and reproduction of the pathogens of citrus canker and kiwifruit canker.

[0009] Compared with other purely natural plant-derived biological pesticides or chemical pesticides, the oregano oil and carvacrol in the present application have excellent preventive and therapeutic effects on citrus canker and kiwi fruit canker.

[0010] In a preferred embodiment of the present invention, the fungicide further includes an auxiliary agent, and the auxiliary agent includes one or more of a surfactant, a filler, a solvent, a carrier, an emulsifier, a dispersant, a foaming agent, a defoaming agent, a wetting agent, a thickener, a penetrant, a stabilizer, an antifreeze agent, a film-forming agent, a color paste, and a flavor. The active ingredient accounts for 0.5 to 95.0% of the total mass percentage of the fungicide. Preferably, the active ingredient accounts for 1.0 to 50.0% of the total mass percentage of the fungicide. Further preferably, the active ingredient accounts for 5.0 to 25.0% of the total mass percentage of the fungicide.

[0011] According to an embodiment of the present invention, the fungicide may further include a stabilizer, such as a low-temperature stabilizer, a preservative, an antioxidant, a light stabilizer or other auxiliary agents for improving chemical and / or physical stability.

[0012] According to an embodiment of the present invention, the fungicide can be prepared in a known manner, for example, by mixing oregano oil or carvacrol with an adjuvant.

[0013] According to an embodiment of the present invention, the active ingredient is mixed with an adjuvant to form a dosage form suitable for use in agriculture, and the dosage form can be selected from one or more of an aqueous emulsion, a microemulsion, an oil emulsion, an emulsifiable concentrate, a latex, a paste, an ointment, a dispersible liquid, a soluble solution, a soluble gel, an oil, a granule, a wettable powder, a water-dispersible granule, a suspension, a microcapsule suspension, an oil suspension, a dispersible oil suspension, and a seed treatment suspension.

[0014] The fungicide of the present invention can be used to treat plants or plant parts, or to allow the active ingredients to act on their environment, habitat or storage space, for example, by dipping, spraying, misting, drip irrigation, injection, flushing, evaporation, spreading, smearing, coating (for example, application to seeds) or seed dressing.

[0015] In some embodiments of the present invention, the dosage form of the bactericide is a microcapsule suspension. The bactericide comprises a core material and a wall material in a mass ratio of 1:5 to 5:1, the core material is an active ingredient, and the wall material is composed of polybutylene succinate and polyhydroxybutyrate in a mass ratio of 1:4 to 4:1; the active ingredient is wrapped in the wall material, preferably, the bactericide comprises a core material and a wall material in a mass ratio of 1:1 to 3:1, and the mass ratio of the wall material composed of polybutylene succinate and polyhydroxybutyrate is 1:1 to 1:1.5.

[0016] The active ingredients oregano oil and carvacrol in the present invention are plant extracts, which are very easy to oxidize and volatilize under natural conditions. When directly applied and exposed to the air in field applications, the active ingredients will be degraded or lost, resulting in a small amount acting on the target and reduced biological activity. The active ingredients are made into microcapsule suspensions, which can encapsulate the effective ingredients, avoid degradation caused by volatilization and ultraviolet rays, improve bioavailability, and significantly improve field prevention effects. The selection of microcapsule wall materials has a great relationship with the encapsulated active ingredients, affecting whether the active ingredients can be fully encapsulated. The ratio in this patent is the optimal ratio of oregano oil and carvacrol relative to the wall material. Too high or too low ratios will result in the active ingredients not being fully encapsulated.

[0017] For the core material of the present application, the wall material prepared by using polylactic acid (PLA) and polybutylene succinate (PBS) in the invention patent with publication number CN108835110B is easy to form capsules, but the prepared microcapsules have irregular morphology, are prone to holes, have reduced encapsulation efficiency, release active ingredients quickly, and have a short duration. Compared with the wall material in the invention patent with publication number CN108835110B or other wall materials, the microcapsules prepared by using polyhydroxybutyrate (PHB) and polybutylene succinate (PBS) in the present application have good encapsulation, regular spherical microcapsule morphology, regular morphology, no agglomeration, higher encapsulation efficiency and drug loading, and better efficacy.

[0018] The preparation method of the bactericide comprises the following steps:

[0019] (1) Preparation of the oil phase: dissolving the active ingredient, polyhydroxybutyrate and polybutylene succinate in a low-boiling point organic solvent to obtain an oil phase containing the active ingredient and the carrier;

[0020] (2) Preparation of aqueous phase: completely dissolving the emulsifying dispersant in water to obtain an aqueous phase;

[0021] (3) Preparation of microcapsules: adding the oil phase containing the active ingredient and the carrier in step (1) to the water phase in step (2), and subjecting the mixture to high-speed shearing at room temperature. After the shearing is completed, a microemulsion is obtained. The microemulsion is stirred at a set temperature until the organic solvent is completely evaporated. After centrifugation and drying, drug-loaded microcapsules are obtained.

[0022] (4) Preparation of microcapsule suspension: Determine the active ingredient loading, then measure the mass of microcapsules, wetting agent, dispersant, thickener, penetration enhancer and stabilizer according to the microcapsule suspension ratio, combine them in a container and shear and disperse them to form a preparation.

[0023] The invention also discloses application of the bactericide in preventing and treating kiwifruit canker disease.

[0024] In a preferred embodiment of the present invention, the active ingredient of the fungicide is carvacrol, the mass concentration of the active ingredient in the fungicide is 4 to 20 mg / L, and the EC of the active ingredient in the fungicide is 50 It is 10.55mg / L.

[0025] In a preferred embodiment of the present invention, the active ingredient of the fungicide is oregano oil, the mass concentration of the active ingredient in the fungicide is 5 to 40 mg / L, and the EC of the active ingredient in the fungicide is 50 It is 15.38mg / L.

[0026] EC of the active ingredient in the fungicide 50 The values ​​were obtained by turbidimetry under laboratory conditions.

[0027] In a preferred embodiment of the present invention, the active ingredient of the fungicide is carvacrol, and the field application mass concentration of the fungicide is 300-800 mg / L, preferably, the field application mass concentration of the fungicide is 500 mg / L.

[0028] In a preferred embodiment of the present invention, the active ingredient of the fungicide is oregano oil, and the mass concentration of the fungicide applied in the field is 300-800 mg / L, preferably, the mass concentration of the fungicide applied in the field is 500 mg / L.

[0029] The preferred mass concentration of the fungicide is determined by using the fungicide in field trials.

[0030] The mass concentration range of the active ingredients in the fungicide can significantly inhibit the growth and reproduction of kiwifruit canker pathogens.

[0031] The invention also discloses application of the fungicide in preventing and treating citrus canker.

[0032] In a preferred embodiment of the present invention, the active ingredient of the fungicide is carvacrol, the mass concentration of the active ingredient in the fungicide is 3 to 15 mg / L, and the EC of the active ingredient in the fungicide is 50 It is 7.52mg / L.

[0033] In a preferred embodiment of the present invention, the active ingredient of the fungicide is carvacrol, and the mass concentration of the fungicide is 300-800 mg / L, preferably, the mass concentration of the fungicide is 500 mg / L.

[0034] The preferred mass concentration of the fungicide is determined by using the fungicide in field trials.

[0035] The mass concentration range of the active ingredients in the fungicide can significantly inhibit the growth and reproduction of citrus canker pathogens.

[0036] Compared with the prior art, the present invention has the following beneficial effects:

[0037] (1) The present invention can effectively inhibit citrus canker bacteria, has a rapid onset of action, leaves no residue, and improves the quality of citrus. It has a better effect than 77% basic copper sulfate water-dispersible granules.

[0038] (2) The present invention can effectively inhibit kiwifruit canker bacteria, has a rapid onset of action, leaves no residue, and improves the quality of kiwifruit. It has a better effect than 5% kasugamycin aqueous solution. BRIEF DESCRIPTION OF THE DRAWINGS

[0039] Figure 1 This is the result of measuring the indoor toxicity of carvacrol against kiwifruit canker pathogen using turbidimetry in Example 1; as the concentration of the active ingredient increases, the color of the bacterial solution gradually becomes clear, indicating that a higher concentration of carvacrol can significantly inhibit the growth and reproduction of kiwifruit canker pathogens.

[0040] Figure 2 This is a picture of the 10% carvacrol microcapsule suspension prepared in Example 2 being used to prevent and treat kiwifruit canker. There were no obvious symptoms of canker on the plants after the application, indicating that the 10% carvacrol microcapsule suspension has an obvious field control effect.

[0041] Figure 3 This is a comparison of the pictures after the use of 4% kasugamycin aqueous solution for the prevention and treatment of kiwifruit canker. After the use of kasugamycin, there were obvious symptoms of canker on the leaves, indicating that the ability of 4% kasugamycin aqueous solution to prevent and treat kiwifruit canker is weak.

[0042] Figure 4 This is the result of measuring the indoor toxicity of carvacrol against citrus canker pathogen using turbidimetry in Example 3; as the concentration of the active ingredient increases, the color of the bacterial solution gradually becomes clear, indicating that a higher concentration of carvacrol can significantly inhibit the growth and reproduction of kiwifruit canker pathogens.

[0043] Figure 5This is a picture of the 10% carvacrol microcapsule suspension prepared in Example 4 being used to control citrus canker. There were no obvious symptoms of canker on the plants after the application, indicating that the 10% carvacrol microcapsule suspension has an obvious field control effect.

[0044] Figure 6 To compare the pictures after using 77% basic copper sulfate water dispersible granules to prevent and control citrus canker; after using 77% basic copper sulfate water dispersible granules, there are obvious symptoms of canker on the leaves, indicating that the ability of 77% basic copper sulfate water dispersible granules to prevent and control kiwi fruit canker is weak.

[0045] Figure 7 This is the result of the indoor toxicity test of oregano oil against kiwifruit canker pathogen using turbidimetry in Example 5; as the concentration of the active ingredient increases, the color of the bacterial solution gradually becomes clear, indicating that a higher concentration of oregano oil can significantly inhibit the growth of kiwifruit canker pathogen.

[0046] Figure 8 This is a picture of the 10% oregano oil microcapsule suspension prepared in Example 6 being used to control kiwifruit canker. There were no obvious symptoms of canker on the plants after the application, indicating that the 10% oregano oil microcapsule suspension has an obvious field control effect.

[0047] Fig. 9 This is a comparison of the pictures after the use of 4% kasugamycin aqueous solution for the prevention and treatment of kiwifruit canker. After the use of kasugamycin, there were obvious symptoms of canker on the leaves, indicating that the ability of 4% kasugamycin aqueous solution to prevent and treat kiwifruit canker is weak. DETAILED DESCRIPTION

[0048] Embodiment 1:

[0049] In vitro inhibitory activity test method of carvacrol against kiwifruit canker pathogen Pseudomonas syringae pv.actinidiae (Psa):

[0050] Bioassay materials: A strong pathogenic physiological subspecies of the pathogen of kiwifruit canker, Actinidia xanthomonas subspecies, collected, isolated and identified by the inventors. The strain was activated on LB solid medium and cultured at 28°C for 3 days before use.

[0051] Experimental instruments and consumables: UV spectrometer, constant temperature incubator, constant temperature shaker, centrifuge tubes, and gun tips.

[0052] Bioassay steps: Preparation of culture medium: LB liquid culture medium: 10 g tryptone, 5 g yeast extract, 10 g sodium chloride, dilute to 1000 ml with distilled water, and adjust the pH to 7.4 with NaOH.

[0053] Preparation of bacterial suspension: Activate the strain on LB solid culture medium, invert and culture at 28℃ for 3 days, then gently scrape a small amount of colonies into LB liquid culture medium with the tip of a pipette on a clean workbench, and culture on a shaker at 28℃ and 200rpm until the colonies are completely dispersed without lumps of precipitation, then use sterile water to dilute the kiwifruit canker bacteria into a bacterial suspension with an absorbance of 0.1 at 600nm on a UV spectrophotometer.

[0054] The turbidimetric method was used to determine the toxicity of the active ingredients to kiwifruit canker pathogens. Five concentration gradients of the active ingredients were set, and 100 mL of LB culture medium was set for each gradient. Then 100 μL of the prepared kiwifruit canker pathogenic bacteria solution was added and placed in a constant temperature oscillator for 24 hours at 28°C and 180 r / min. The LB culture medium without the addition of active ingredients was used as CK, and 3 replicates were performed for each test group. Then, the solubility of the bacterial solution was determined at 600 nm using an ultraviolet spectrometer, and the toxicity regression equation, EC 50 Value and correlation coefficient. The growth inhibition rate was calculated according to formula 1-1:

[0055]

[0056] Table 1 Turbidimetric determination of the toxicity of carvacrol to kiwifruit canker pathogens in the laboratory

[0057]

[0058] Embodiment 2:

[0059] A preparation for preventing and treating kiwifruit canker. It is prepared from the following components in parts by weight: 98 parts of deionized water, 2 parts of polyvinyl alcohol, 10 parts of carvacrol, 2.25 parts of polybutylene succinate (PBS), 2.75 parts of polyhydroxybutyrate (PHB), and 30 parts of dichloromethane. During preparation, 98g of deionized water is measured in a conical flask, 2g of polyvinyl alcohol is slowly added, and a digital magnetic stirrer is used to heat it to 60°C and stir it at a constant temperature and high speed to completely dissolve it, and then it is cooled to room temperature to prepare an aqueous phase. PBS:PHB (9:11) is used as the wall material, and the active ingredient carvacrol is used as the core material, and the core-to-wall ratio is 2:1. 2.25g of polybutylene succinate (PBS) and 2.75g of polyhydroxybutyrate (PHB) are dissolved in 30mL of dichloromethane, fully stirred on a magnetic stirrer, and then the active ingredient carvacrol is added thereto and continued to stir and dissolve to obtain an oil phase. After pouring the oil phase into the water phase, use a T25 digital disperser to emulsify and shear at a speed of 8000r / min for 5 minutes to prepare a stable water-in-oil mixed emulsion. Stir it on a magnetic stirrer at a speed of 600r / min for 6 to 7 hours until the solvent dichloromethane is completely evaporated and the microcapsules are solidified. Separate the microcapsules and determine the active ingredient loading. Measure the mass of microcapsules, wetting agents, dispersants, thickeners, penetration enhancers and stabilizers according to the ratio of microcapsule suspensions, combine them in a container and shear and disperse to form a preparation. When using, dilute the preparation and water at a mass ratio of 1:200 and spray the kiwifruit plants.

[0060] The preparation for preventing and treating kiwifruit canker prepared in Example 2 was used in a control experiment according to the method of use. The results are shown in Table 2 below:

[0061] Table 2 Field investigation results of the efficacy of 10% carvacrol microcapsule suspension against kiwifruit canker

[0062]

[0063]

[0064] Embodiment 3:

[0065] In vitro inhibitory activity test method of carvacrol against citrus canker pathogens:

[0066] Bioassay materials: Citrus canker pathogen with strong pathogenicity, Xanthomonas citri subsp. citri (Xcc) LYGJ3-5, collected, isolated and identified by the inventors. The strain was activated on LB solid medium and cultured at 28°C for 3 days before use.

[0067] Experimental instruments and consumables: UV spectrometer, constant temperature incubator, constant temperature shaker, centrifuge tubes, and gun tips.

[0068] Bioassay steps: Preparation of culture medium: LB liquid culture medium: 10 g tryptone, 5 g yeast extract, 10 g sodium chloride, dilute to 1000 ml with distilled water, and adjust the pH to 7.4 with NaOH.

[0069] Preparation of bacterial suspension: Activate the strain on LB solid culture medium, invert and culture at 28°C for 3 days, then gently scrape a small amount of colonies into LB liquid culture medium with the tip of a pipette on a clean workbench, and culture on a shaker at 28°C and 200 rpm until the colonies are completely dispersed without lumps of precipitation. Then use sterile water to dilute the citrus canker bacteria into a bacterial suspension with an absorbance of 0.1 at 600nm on a UV spectrophotometer.

[0070] The turbidimetric method was used to determine the toxicity of the active ingredient to citrus canker bacteria. Five concentration gradients of the active ingredient were set, and 100 mL of LB culture medium was set for each gradient. Then 100 μL of the prepared citrus canker bacteria solution was added and placed in a constant temperature oscillator for 24 hours at 28°C and 180 r / min. The LB culture medium without the active ingredient was used as CK, and 3 replicates were made for each test group. Then, the solubility of the bacterial solution was determined at 600 nm using an ultraviolet spectrometer, and the toxicity regression equation, EC 50 Value and correlation coefficient. The growth inhibition rate is calculated according to formula 3-1:

[0071]

[0072] Table 3 Results of turbidimetric determination of the toxicity of carvacrol to citrus canker in the laboratory

[0073]

[0074] Embodiment 4:

[0075] A preparation for preventing and treating citrus canker. It is prepared from the following components in parts by weight: 98 parts of deionized water, 2 parts of polyvinyl alcohol, 10 parts of carvacrol, 2.25 parts of polybutylene succinate (PBS), 2.75 parts of polyhydroxybutyrate (PHB), and 30 parts of dichloromethane. During preparation, 98g of deionized water is measured in a conical flask, 2g of polyvinyl alcohol is slowly added, and a digital magnetic stirrer is used to heat it to 60°C and stir it at a constant temperature and high speed to completely dissolve it, and then it is cooled to room temperature to prepare an aqueous phase. PBS:PHB (9:11) is used as the wall material, and the active ingredient carvacrol is used as the core material, and the core-to-wall ratio is 2:1. 2.25g of polybutylene succinate (PBS) and 2.75g of polyhydroxybutyrate (PHB) are dissolved in 30mL of dichloromethane, fully stirred on a magnetic stirrer, and then the active ingredient carvacrol is added thereto and continued to stir and dissolve to obtain an oil phase. After pouring the oil phase into the water phase, use a T25 digital disperser to emulsify and shear at a speed of 8000r / min for 5 minutes to prepare a stable water-in-oil mixed emulsion. Stir it on a magnetic stirrer at a speed of 600r / min for 6 to 7 hours until the solvent dichloromethane is completely evaporated and the microcapsules are solidified. Separate the microcapsules and determine the active ingredient loading. Measure the mass of microcapsules, wetting agents, dispersants, thickeners, penetration enhancers and stabilizers according to the ratio of microcapsule suspensions, combine them in a container and shear and disperse to form a preparation. When using, dilute the preparation and water at a mass ratio of 1:200 and spray the kiwifruit plants.

[0076] The fungicide for preventing and treating citrus canker prepared by the preparation method of Example 4 was used in a control experiment at a navel orange planting base according to the method of use. The results are shown in Table 4 below:

[0077] Table 4 Field investigation results of the efficacy of 10% carvacrol microcapsule suspension against citrus canker

[0078]

[0079] Embodiment 5:

[0080] Test method for in vitro inhibitory activity of oregano oil against kiwifruit canker pathogen Pseudomonas syringae pv. Actinidiae:

[0081] Bioassay materials: A strong pathogenic physiological subspecies of the pathogen of kiwifruit canker, Actinidia xanthomonas subspecies, collected, isolated and identified by the inventors. The strain was activated on LB solid medium and cultured at 28°C for 3 days before use.

[0082] Experimental instruments and consumables: UV spectrometer, constant temperature incubator, constant temperature shaker, centrifuge tubes, and gun tips.

[0083] Bioassay steps: Preparation of culture medium: LB liquid culture medium: 10 g tryptone, 5 g yeast extract, 10 g sodium chloride, dilute to 1000 mL with distilled water, and adjust the pH to 7.4 with NaOH.

[0084] Preparation of bacterial suspension: The strain was activated on LB solid culture medium, and after inverted culture at 28°C for 3 days, a small amount of colonies was gently scraped into LB liquid culture medium with the tip of a pipette on a clean workbench, and cultured on a shaker at 28°C and 200 rpm until the colonies were completely dispersed without lumps of precipitation. Then, the kiwifruit canker bacteria was diluted with sterile water to a bacterial suspension with an absorbance of 0.1 at 600nm on a UV spectrophotometer.

[0085] The turbidimetric method was used to determine the toxicity of the active ingredients to kiwifruit canker pathogens. Five concentration gradients of the active ingredients were set, and 100 mL of LB culture medium was set for each gradient. Then 100 μL of the prepared kiwifruit canker pathogenic bacteria solution was added and placed in a constant temperature oscillator for 24 hours at 28°C and 180 r / min. The LB culture medium without active ingredients was used as CK, and 3 replicates were performed for each test group. Then, the solubility of the bacterial solution was determined at 600 nm using an ultraviolet spectrometer, and the toxicity regression equation, EC 50 Value and correlation coefficient. The growth inhibition rate is calculated according to formula 5-1:

[0086]

[0087] Table 5 Turbidimetric determination of oregano oil against kiwifruit canker indoor toxicity results

[0088]

[0089] Embodiment 6:

[0090] A preparation for preventing and treating kiwifruit canker. It is prepared from the following components in parts by weight: 98 parts of deionized water, 2 parts of polyvinyl alcohol, 10 parts of oregano oil, 2 parts of polybutylene succinate (PBS), 3 parts of polyhydroxybutyrate (PHB), and 30 parts of dichloromethane. During preparation, 98g of deionized water is measured in a conical flask, 2g of polyvinyl alcohol is slowly added, and a digital magnetic stirrer is used to heat it to 60°C and stir it at a constant temperature and high speed to completely dissolve it, and it is cooled to room temperature to prepare an aqueous phase. PBS:PHB (2:3) is used as the wall material, and the active ingredient carvone is used as the core material, and the core-to-wall ratio is 2:1. 2g of polybutylene succinate (PBS) and 3g of polyhydroxybutyrate (PHB) are dissolved in 30mL of dichloromethane, fully stirred on a magnetic stirrer, and then the active ingredient carvone is added thereto and continued to stir and dissolve to obtain an oil phase. After pouring the oil phase into the water phase, use a T25 digital disperser to emulsify and shear at a speed of 8000r / min for 5 minutes to prepare a stable water-in-oil mixed emulsion. Stir it on a magnetic stirrer at a speed of 600r / min for 6 to 7 hours until the solvent dichloromethane is completely evaporated and the microcapsules are solidified. Separate the microcapsules and determine the active ingredient loading. Measure the mass of microcapsules, wetting agents, dispersants, thickeners, penetration enhancers and stabilizers according to the ratio of microcapsule suspensions, combine them in a container and shear and disperse to form a preparation. When using, dilute the preparation and water at a mass ratio of 1:200 and spray the kiwifruit plants.

[0091] Table 6 Field investigation results of the efficacy of 10% oregano oil microcapsule suspension on kiwifruit canker

[0092]

Claims

1. Use of a fungicide in preventing and treating citrus canker, characterized in that: The fungicide comprises an active ingredient, and the active ingredient is carvacrol; The mass concentration of the active ingredient in the fungicide is 3-15 mg / L, and the EC 50 7.52mg / L; The mass concentration of the fungicide applied in the field is 300-800 mg / L; The fungicide dosage form is a microcapsule suspension, wherein the microcapsule suspension comprises a core material and a wall material in a mass ratio of 1:1 to 3:1, the core material is an active ingredient, and the wall material is composed of polybutylene succinate and polyhydroxybutyrate in a mass ratio of 1:1 to 1:1.5; the active ingredient is wrapped in the wall material.

2. The use of the fungicide according to claim 1 in preventing and treating citrus canker, characterized in that: The field application mass concentration of the fungicide is 500 mg / L.